New patent expiration for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Which pharmaceutical companies have the most gum dosed drugs?

This chart shows the pharmaceutical companies with the most gum dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gum dosed drugs…
The post Which pharmaceutical companies have the most gum do…


Drug Patent Expirations for Nov 16, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. PRELAY (troglitazone) Sankyo Patent number: 5,859,037 Expiration Date: Nov 13, 2017 PRELAY (troglitazone) Sankyo Patent number: 6,011,049 Expiration Date: Nov 13, 2017 STARLIX (nateglinide) Novartis Patent […]


New patent for Novo Nordisk drug SAXENDA

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Novo Nordisk drug SAXENDA appeared first on DrugPa…


New patent for Novo Nordisk drug NORDITROPIN NORDIFLEX

Annual Drug Patent Expirations for NORDITROPIN+NORDIFLEX Norditropin Nordiflex is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Novo Nordisk drug NORDITROPIN…


New patent for Novo Nordisk drug NORDITROPIN FLEXPRO

Annual Drug Patent Expirations for NORDITROPIN+FLEXPRO Norditropin Flexpro is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Novo Nordisk drug NORDITROPIN FLE…


New patent for Novartis Pharms drug SIGNIFOR LAR

Annual Drug Patent Expirations for SIGNIFOR+LAR Signifor Lar is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. There are…
The post New patent for Novartis Pharms drug SIGNIFOR LAR appeared f…


New patent for Bionpharma Inc drug NAPROXEN SODIUM

Annual Drug Patent Expirations for NAPROXEN+SODIUM Naproxen Sodium is a drug marketed by Hamilton Pharms, Glenmark Pharms Ltd, Actavis Labs Fl Inc, Purepac Pharm, Bionpharma Inc, Aurobindo Pharma Ltd, Ivax…
The post New patent for Bionpharma Inc …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: